Improved Outcomes Assessment in Arthritis and Aging(RMI)
Improved Outcomes Assessment in Arthritis and Aging(RMI)
批准号:
7488592
负责人:
James F Fries
金额:
$101.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-28 至 2009-09-29
关键词:
AdoptionAgeAgingAmericanAreaArthritisCalibrationCenters for Disease Control and Prevention (U.S.)ChronicChronic DiseaseClinicalClinical ResearchClinical TrialsCommunitiesComputersConditionConsensusData SetData SourcesDatabasesDevelopmentDiseaseFeasibility StudiesFloorGeneral PopulationGeneric DrugsGoalsHandheld ComputersHealthHealth StatusImpairmentIndividualInformation SystemsMeasurementMeasuresMedicalMedicare/MedicaidMethodsMetricMinority GroupsModelingModemsMusculoskeletalMusculoskeletal DiseasesNew Drug ApprovalsObservational StudyOnline SystemsOutcomeOutcome AssessmentOutcome MeasurePatient Outcomes AssessmentsPatientsPerformancePliabilityPopulationPropertyPsychometricsQuestionnairesRandomized Controlled Clinical TrialsRangeRateRelative (related person)ResearchResearch InfrastructureResearch PersonnelRespondentRheumatismRheumatoid ArthritisRheumatologyScoreSiteSpecific qualifier valueSurveysTechniquesTelephoneTelephone InterviewsTestingUnited States Food and Drug AdministrationUnited States National Institutes of HealthValidity and ReliabilityVoiceWorkWorld Health Organizationbasecollegecomputerizedconceptcost effectivedesignexperienceimprovedinnovationinstrumentrepositoryresponsesimulationsoundtheoriestooltrial comparing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Patient-reported outcomes (PROs) are increasingly accepted as important outcomes. We seek to extensively advance outcome assessment in arthritis and aging by developing improved instruments using item response theory (IRT) and computerized adaptive testing (CAT). The use of existing tools has been limited by impracticality (respondent burden) and difficulties comparing study results across tools. Shorter questionnaires have proven more practical, but "ceiling" and "floor" effects typically result from measuring a limited range within each health domain. Further, brief questionnaires (e.g., the SF- 36, the HAQ) lack the precision necessary to reliably detect changes in individual patient scores. To these issues, we bring a team with extensive experience in developing, evaluating, and implementing the most frequently used PRO assessment instruments in rheumatic diseases, large longitudinal patient datasets in musculoskeletal disease and aging, and experience with innovative approaches to the application of IRT and CAT.
We propose to realize eight specific aims related to item bank development, psychometric testing, and CAT development, with a goal of delivering psychometrically sound tools to facilitate NIH clinical research. This project will build on the substantial infrastructure of Arthritis, Rheumatism, and Aging Medical Information System (ARAMIS) longitudinal data banks for item development, IRT testing, and CAT simulation and development. It will culminate in a four-ann randomized trial comparing enhanced traditional static and dynamic tools in terms of relative sensitivity to change. The first network project investigates the conceptual hierarchies of PROMIS domains and the utility of aggregations of domains seeking consensus, combining generic and disease-specific attributes, and envisioning a single generic/specific CAT application across diverse chronic conditions. The second network project examines the impact of survey mode on PROs and seeks to understand which interface options (e.g., telephone interview, telephone Interactive Voice Response, web-based desktop computer, and handheld computer) are most accessible across types of impairment and other stratified variables. Proposed iterative randomized trials seek to elucidate how administration mode influences dynamic PROs.
Item banks for musculoskeletal diseases, aging, and other conditions, and improvement of responsiveness, reliability and validity will better represent the patient's perspective and enable more cost effective clinical research. Key Words: Rheumatic, Musculoskeletal, Aging, Health Outcomes, Computer Adaptive Testing (CAT), Item Response Theory (IRT).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improved Outcomes Assessment in Arthritis and Aging(RMI)
-
批准号:7286120
-
项目类别:
-
资助金额:$74.57万
-
财政年份:2004
-
负责人:James F Fries
-
依托单位:
Improved Outcomes Assessment in Arthritis and Aging(RMI)
-
批准号:6954220
-
项目类别:
-
资助金额:$78.64万
-
财政年份:2004
-
负责人:James F Fries
-
依托单位:
Improved Outcomes Assessment in Arthritis/Aging (RMI)
-
批准号:6878206
-
项目类别:
-
资助金额:$78.49万
-
财政年份:2004
-
负责人:James F Fries
-
依托单位:
Improved Outcomes Assessment in Arthritis and Aging(RMI)
-
批准号:7119544
-
项目类别:
-
资助金额:$76.79万
-
财政年份:2004
-
负责人:James F Fries
-
依托单位:
PATIENT OUTCOME IN RA WITH EARLY ANTIRHEUMATIC THERAPY
-
批准号:6583185
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2002
-
负责人:James F Fries
-
依托单位:
CORE--STATISTICS, METHODS, OUTCOMES AND COMPUTER CENTER
-
批准号:6583189
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2002
-
负责人:James F Fries
-
依托单位:
CORE--INCEPTION COHORT OF RHEUMATOID ARTHRITIS PATIENTS
-
批准号:6583190
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2002
-
负责人:James F Fries
-
依托单位:
EXERCISE, DISABILITY, OSTEOARTHRITIS AND COSTS
-
批准号:6372223
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
EXERCISE, DISABILITY, OSTEOARTHRITIS AND COSTS
-
批准号:6042051
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
EXERCISE, DISABILITY, OSTEOARTHRITIS AND COSTS
-
批准号:6792596
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
EXERCISE, DISABILITY, OSTEOARTHRITIS AND COSTS
-
批准号:7278057
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
CORE--BIOSTATISTICAL/METHODOLOGIC/OUTCOME ASSESMENT/COMPUTER SCIENCE
-
批准号:6318274
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
EXERCISE, DISABILITY, OSTEOARTHRITIS AND COSTS
-
批准号:6650374
-
项目类别:
-
资助金额:$37.25万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
IMPROVING PATIENT OUTCOME IN RA WITH EARLY ANTIRHEUMATIC DRUG THERAPY
-
批准号:6318270
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
EXERCISE, DISABILITY, OSTEOARTHRITIS AND COSTS
-
批准号:6533794
-
项目类别:
-
资助金额:$34.18万
-
财政年份:2000
-
负责人:James F Fries
-
依托单位:
IMPROVING PATIENT OUTCOME IN RA WITH EARLY ANTIRHEUMATIC DRUG THERAPY
-
批准号:6100636
-
项目类别:
-
资助金额:$21.52万
-
财政年份:1999
-
负责人:James F Fries
-
依托单位:
CORE--BIOSTATISTICAL/METHODOLOGIC/OUTCOME ASSESMENT/COMPUTER SCIENCE
-
批准号:6100640
-
项目类别:
-
资助金额:$21.52万
-
财政年份:1999
-
负责人:James F Fries
-
依托单位:
IMPROVING PATIENT OUTCOME IN RA WITH EARLY ANTIRHEUMATIC DRUG THERAPY
-
批准号:6268444
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1998
-
负责人:James F Fries
-
依托单位:
CORE--BIOSTATISTICAL/METHODOLOGIC/OUTCOME ASSESMENT/COMPUTER SCIENCE
-
批准号:6268448
-
项目类别:
-
资助金额:$20.89万
-
财政年份:1998
-
负责人:James F Fries
-
依托单位:
CORE--BIOSTATISTICAL/METHODOLOGIC/OUTCOME ASSESMENT/COMPUTER SCIENCE
-
批准号:6235844
-
项目类别:
-
资助金额:$20.33万
-
财政年份:1997
-
负责人:James F Fries
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: